Address

Precise Investors

Sunday, January 23, 2022
Trading

SGX Nifty 50 Futures trade marginally lower

SGX

The Nifty 50 Futures listed on the Singapore-based Exchange SGX was trading marginally lower by 0.4% at 17,380

The Nifty 50 Futures listed on the Singapore-based Exchange SGX, an early indicator for Nifty50, was trading marginally lower by 0.4% at 17,380 at 7:55 am on Friday, indicating the Dalal Street to make a negative to muted start today, tracking weakness across some Asian markets, despite a broad rally across the Wall Street overnight. At the same time, the Dow Jones Futures was trading 0.31% lower.

Indian equities were higher at the close on Thursday, as gains in the Power, IT and Technology sectors lead shares higher. At the close in NSE, the Nifty 50 gained 1.37%, while the BSE Sensex 30 index added 1.35%.

Biocon Pharma, a subsidiary of the biotech major received the approval for its abbreviated new drug application for Mycophenolic Acid from the US health regulator, USFDA.

Electric power distribution company Tata Power Co. Ltd’s shareholders have approved the revision of a series of arrangements to keep its subsidiary Tata Power Solar Systems Ltd as an independent entity.

State-owned oil major, ONGC, entered into an agreement with the Solar Energy Corporation of India on Thursday, to scale up its clean energy projects, in a bid to grab a stronger hold in the renewable space.

Defence ammunition manufacturer Bharat Dynamics Ltd and the Indian Army have signed a contract worth Rs 471.41 crore for refurbishing IGLA, which will last for 10 years, informed the defence PSU in a regulatory filing.

According to the domestic rating agency Crisil, the retail prices of cement is expected to rise further by Rs 15-20 in the upcoming few months and could touch an all-time high of nearly Rs 400/bag, due to the increasing cost pressure of inputs commodities, like coal and diesel.

Important:

The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.

Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.

There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.

Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.

Leave a Reply